Skip to content
Home
Team
Principal Investigator
Lab Team
Lab Alumni
Research
Overview
Basic Research
Clinical Trials
Correlative Studies
Funding
Publications
Immune Monitoring
Process Development
Press
Newsletters
Articles
Videos
Contribute
Donate
Join The Lab
×
Home
Team
Principal Investigator
Lab Team
Lab Alumni
Research
Overview
Basic Research
Clinical Trials
Correlative Studies
Funding
Publications
Immune Monitoring
Process Development
Press
Newsletters
Articles
Videos
Contribute
Donate
Join The Lab
PRESS
Maus Lab Newsletters
What's New With The Car-tologists
October 2021
Read More
CATCH UP WITH THE CAR-TOLOGISTS
March, 2022
Read More
SUMMER UPDATE FROM THE CAR-TOLOGISTS
AUGUST, 2022
Read More
Articles
IMMUNO-ONCOLOGY 360° Autumn 2021 Newsletter
Read More
POTENTIATING NOVEL ENGINEERED CELLULAR THERAPIES FOR SOLID TUMORS
Read More
SU2C’S RESEARCH IN THE FIGHT AGAINST GLIOBLASTOMA
Read More
The Next Cancer Breakthroughs
Read More
Massachusetts clinical trial shows 'dramatic and rapid' progress against glioblastoma tumors
Living drugs that reprogram patients’ immune cells show early promise against hard-to-treat brain tumors
Videos
Video Playlist
1
/4
videos
1
Dr. Marcela Maus: A Researcher's Point of View of CAR T-Cell Therapy
01:19
2
Potentiating Novel Engineered Cellular Therapies for Solid Tumors
02:27
3
Testing the Limits: The Potential of CAR T-Cell Therapy
07:11
4
Meet an IRG Recipient: Marcela Maus
01:11
Contribute